Macitentan to Prevent PRVO

NCT05946811 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was cancelled by funding agency before starting enrollment.

Conditions

Pulmonary Embolism

Interventions

DRUG: Macitentan 10mg

Sponsor

University of Maryland, Baltimore